Dr Paul Fitzgerald Mester, MD - Medicare Internal Medicine in Iowa City, IA

Dr Paul Fitzgerald Mester, MD is a medicare enrolled "Internal Medicine" physician in Iowa City, Iowa. He went to University Of South Carolina School Of Medicine and graduated in 2017 and has 7 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice State University Of Iowa and his current practice location is 200 Hawkins Dr, Iowa City, Iowa. You can reach out to his office (for appointments etc.) via phone at (319) 356-4019.

Dr Paul Fitzgerald Mester is licensed to practice in Iowa (license number MD-49850) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1215464847.

Contact Information

Dr Paul Fitzgerald Mester, MD
200 Hawkins Dr,
Iowa City, IA 52242-1009
(319) 356-4019
(319) 353-8073



Physician's Profile

Full NameDr Paul Fitzgerald Mester
GenderMale
SpecialityInternal Medicine
Experience7 Years
Location200 Hawkins Dr, Iowa City, Iowa
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Paul Fitzgerald Mester attended and graduated from University Of South Carolina School Of Medicine in 2017
  NPI Data:
  • NPI Number: 1215464847
  • Provider Enumeration Date: 05/13/2017
  • Last Update Date: 08/29/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 6800168535
  • Enrollment ID: I20220715002483

Medical Identifiers

Medical identifiers for Dr Paul Fitzgerald Mester such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1215464847NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist MD-49850 (Iowa)Secondary
207R00000XInternal Medicine MD-49850 (Iowa)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Iowa Hospital & ClinicsIowa city, IAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
State University Of Iowa76188842301476

News Archive

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

Studies aim to address urgent need to identify possible new methods for mesothelioma treatment

Mesothelioma is a very aggressive cancer associated with asbestos exposure, which is usually diagnosed in an advanced stage. So far no therapeutic strategy has proven effective against this deadly cancer and the prognosis remains very poor with only few exceptions.

First case of treating cystic fibrosis and Crohn's disease with infliximab

Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive. CF involves an anomalous function of the exocrine glands, caused by a mutation of a gene (cystic fibrosis transmembrane conductance regulator, CFTR) located on chromosome 7, which codes for a protein involved in ion transport through the cell membrane.

New study quantifies impact of ER closures on neighborhoods

The study, which appeared in Health Affairs, focused on California and is thought to be the first of its kind to examine the impact of emergency department closures on the quality of patient care.

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Patients who have persistently high levels of inflammation following percutaneous coronary intervention for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of 7,026 patients published in the European Heart Journal.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Paul Fitzgerald Mester allows following entities to bill medicare on his behalf.
Entity NameState University Of Iowa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477554814
PECOS PAC ID: 7618884230
Enrollment ID: O20031107000060

News Archive

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

Studies aim to address urgent need to identify possible new methods for mesothelioma treatment

Mesothelioma is a very aggressive cancer associated with asbestos exposure, which is usually diagnosed in an advanced stage. So far no therapeutic strategy has proven effective against this deadly cancer and the prognosis remains very poor with only few exceptions.

First case of treating cystic fibrosis and Crohn's disease with infliximab

Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive. CF involves an anomalous function of the exocrine glands, caused by a mutation of a gene (cystic fibrosis transmembrane conductance regulator, CFTR) located on chromosome 7, which codes for a protein involved in ion transport through the cell membrane.

New study quantifies impact of ER closures on neighborhoods

The study, which appeared in Health Affairs, focused on California and is thought to be the first of its kind to examine the impact of emergency department closures on the quality of patient care.

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Patients who have persistently high levels of inflammation following percutaneous coronary intervention for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of 7,026 patients published in the European Heart Journal.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paul Fitzgerald Mester is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Paul Fitzgerald Mester, MD
200 Hawkins Dr,
Iowa City, IA 52242-1009

Ph: () -
Dr Paul Fitzgerald Mester, MD
200 Hawkins Dr,
Iowa City, IA 52242-1009

Ph: (319) 356-4019

News Archive

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

Studies aim to address urgent need to identify possible new methods for mesothelioma treatment

Mesothelioma is a very aggressive cancer associated with asbestos exposure, which is usually diagnosed in an advanced stage. So far no therapeutic strategy has proven effective against this deadly cancer and the prognosis remains very poor with only few exceptions.

First case of treating cystic fibrosis and Crohn's disease with infliximab

Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive. CF involves an anomalous function of the exocrine glands, caused by a mutation of a gene (cystic fibrosis transmembrane conductance regulator, CFTR) located on chromosome 7, which codes for a protein involved in ion transport through the cell membrane.

New study quantifies impact of ER closures on neighborhoods

The study, which appeared in Health Affairs, focused on California and is thought to be the first of its kind to examine the impact of emergency department closures on the quality of patient care.

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Patients who have persistently high levels of inflammation following percutaneous coronary intervention for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of 7,026 patients published in the European Heart Journal.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Iowa City, IA

Rami G. El Abiad, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-356-4901    Fax: 319-384-8559
Grerk Sutamtewagul, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 200 Hawkins Dr, Dept Of Internal Medicine, Iowa City, IA 52242
Phone: 319-356-1616    Fax: 319-353-8383
Dr. Kaleb Tanner Veit, D.O.
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Drive, Iowa City, IA 52242
Phone: 319-353-6239    Fax: 319-353-6406
Dr. Elizabeth R Bowen, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 200 Hawkins Dr, Department Of Internal Medicine, Iowa City, IA 52242
Phone: 319-353-7842    Fax: 319-353-7850
Balarama Krishna Surapaneni,
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-356-4019    Fax: 319-353-8073
Soorih Shaikh, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-356-2148    Fax: 319-353-8383
Dr. Richard Ellis Larew, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2460 Towncrest Dr, Iowa City, IA 52240
Phone: 319-338-7862    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.